The Herpes Marker Testing Market is expected to register a CAGR of 6% from 2025 to 2031, with a market size expanding from US$ XX million in 2024 to US$ XX Million by 2031.
The Herpes Marker Testing Market report covers segmental analysis by Type (HSV-1, HSV-2); Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); , and Geography (North America, Europe, Asia Pacific, and South and Central America). The global analysis is further broken down at the regional level and major countries. The report Offers the Value in US$ for the above analysis and segments.
Purpose of the ReportThe report Herpes Marker Testing Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:
- Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
- Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
- Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.
Herpes Marker Testing Market Segmentation
Type- HSV-1
- HSV-2
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Strategic Insights
Herpes Marker Testing Market Growth Drivers- Growing Adoption of Home Testing Kits: The increasing demand for privacy and convenience is driving the adoption of at-home herpes testing kits. These kits allow individuals to test for herpes markers in the comfort of their homes, without the need for a healthcare provider. As more people prefer self-testing due to privacy concerns and ease of use, this trend is significantly contributing to the expansion of the Herpes Marker Testing Market.
- Rising Focus on STI Prevention and Control: Global efforts to reduce the burden of sexually transmitted infections (STIs) are leading to higher adoption rates of herpes marker testing. Governments, NGOs, and healthcare organizations are investing in prevention programs and advocating for regular herpes testing, particularly in high-risk populations. This focus on STI prevention and control is driving steady growth in the market for Herpes Marker Testing.
- Increased Demand for Antiviral Treatment Monitoring: As more individuals are diagnosed with herpes infections and treated with antiviral medications, there is a growing need for monitoring the effectiveness of treatment. Herpes marker testing plays a critical role in tracking viral load and assessing the success of antiviral therapies, driving demand for these tests in both clinical and home care settings.
- Launch of Multi-Infection Panels: The future of Herpes Marker Testing may see the development of multi-infection diagnostic panels. These comprehensive panels will enable the simultaneous testing for multiple sexually transmitted infections (STIs), including herpes, HPV, HIV, and syphilis, using a single sample. Multi-infection panels can streamline the testing process, reduce patient discomfort, and lower testing costs. With healthcare systems focusing on cost-effectiveness and efficiency, this trend is likely to become a key feature in the Herpes Marker Testing Market in the coming years.
- Improvement in Test Sensitivity and Specificity: The continued development of more sensitive and specific herpes marker tests is a critical trend that will drive the Herpes Marker Testing Market forward. Future herpes tests will feature enhanced sensitivity to detect even low viral loads and offer greater specificity to distinguish between different herpes strains (HSV-1 and HSV-2). This will not only reduce the likelihood of false positives or negatives but also allow for more accurate early-stage diagnosis, contributing to better outcomes for patients and improved public health surveillance.
- Wearable Health Devices for Continuous Monitoring: Wearable health technology is poised to revolutionize the way herpes infections are managed. In the future, wearable devices that continuously monitor viral markers or track outbreaks of herpes could become commonplace. These devices will provide patients with real-time data, enabling early intervention and better management of the infection. As part of the broader trend towards digital health, such innovations will create new opportunities for the Herpes Marker Testing Market to integrate with personal health tracking systems.
- Expanding Direct-to-Consumer Testing Options: The growing trend of consumer-driven healthcare presents an exciting opportunity in the Herpes Marker Testing Market. Direct-to-consumer (DTC) herpes testing kits are becoming increasingly popular as people seek privacy and convenience in managing their health. Offering at-home herpes marker testing solutions not only provides patients with ease of access but also allows companies to tap into a broader customer base. This shift in consumer behavior, paired with the increasing focus on self-care, creates a valuable market opportunity for personalized, user-friendly herpes tests.
- Partnerships with Healthcare Providers and Pharmacies: Strategic partnerships with healthcare providers, clinics, and pharmacies present a promising opportunity for expanding the Herpes Marker Testing Market. By integrating herpes testing services into routine screenings or offering testing at pharmacy chains, companies can make herpes marker tests more widely available and accessible. These partnerships can also help raise awareness and normalize testing for herpes, further fueling demand and market growth.
- Development of Multi-Pathogen Detection Platforms: Another key opportunity for the Herpes Marker Testing Market lies in the creation of multi-pathogen detection platforms. Combining herpes testing with panels for other sexually transmitted infections (STIs), such as HIV, chlamydia, and gonorrhea, offers the potential for streamlined testing with a single sample. This all-in-one diagnostic approach would appeal to both patients and healthcare providers, making it more cost-effective and time-efficient. The demand for comprehensive STI testing is expected to rise, creating a lucrative market opportunity for companies that can offer such integrated solutions.
Market Report Scope
Key Selling Points
- Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Herpes Marker Testing Market, providing a holistic landscape.
- Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
- Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
- Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.
The research report on the Herpes Marker Testing Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.
REGIONAL FRAMEWORK
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The Herpes Marker Testing Market is expected to register a CAGR of 6% from 2025-2031.
The major factors impacting the Herpes Marker Testing Market are: Growing Adoption of Home Testing Kits, Rising Focus on STI Prevention and Control, Increased Demand for Antiviral Treatment Monitoring
Key future trends in this market are - Launch of Multi-Infection Panels, Improvement in Test Sensitivity and Specificity and Wearable Health Devices for Continuous Monitoring
Key companies of this market are: Abcam Plc, BioMaerieux SA, Thermo Fisher Scientific, Inc., F. Hoffmann-La Roche Ltd., DiaSorin S.p.A., Quidel Corporation, Luminex Corporation, Merck KGaA, Qiagen N.V., Norgen Biotek Corp.
The report can be delivered in PDF/PPT format; we can also share excel dataset based on the request.
Some of the customization options available based on request are additional 3–5 company profiles and country-specific analysis of 3–5 countries of your choice. Customizations are to be requested/discussed before making final order confirmation, as our team would review the same and check the feasibility.
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Herpes Marker Testing Market - By Type
1.3.2 Herpes Marker Testing Market - By Distribution Channel
1.3.3 Herpes Marker Testing Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. HERPES MARKER TESTING MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. HERPES MARKER TESTING MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. HERPES MARKER TESTING MARKET - GLOBAL MARKET ANALYSIS
6.1. HERPES MARKER TESTING - GLOBAL MARKET OVERVIEW
6.2. HERPES MARKER TESTING - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. HERPES MARKER TESTING MARKET - REVENUE AND FORECASTS TO 2028 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. HSV-1
7.3.1. Overview
7.3.2. HSV-1 Market Forecast and Analysis
7.4. HSV-2
7.4.1. Overview
7.4.2. HSV-2 Market Forecast and Analysis
8. HERPES MARKER TESTING MARKET - REVENUE AND FORECASTS TO 2028 - DISTRIBUTION CHANNEL
8.1. OVERVIEW
8.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
8.3. HOSPITAL PHARMACIES
8.3.1. Overview
8.3.2. Hospital Pharmacies Market Forecast and Analysis
8.4. RETAIL PHARMACIES
8.4.1. Overview
8.4.2. Retail Pharmacies Market Forecast and Analysis
8.5. ONLINE PHARMACIES
8.5.1. Overview
8.5.2. Online Pharmacies Market Forecast and Analysis
9. HERPES MARKER TESTING MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Herpes Marker Testing Market Overview
9.1.2 North America Herpes Marker Testing Market Forecasts and Analysis
9.1.3 North America Herpes Marker Testing Market Forecasts and Analysis - By Type
9.1.4 North America Herpes Marker Testing Market Forecasts and Analysis - By Distribution Channel
9.1.5 North America Herpes Marker Testing Market Forecasts and Analysis - By Countries
9.1.5.1 United States Herpes Marker Testing Market
9.1.5.1.1 United States Herpes Marker Testing Market by Type
9.1.5.1.2 United States Herpes Marker Testing Market by Distribution Channel
9.1.5.2 Canada Herpes Marker Testing Market
9.1.5.2.1 Canada Herpes Marker Testing Market by Type
9.1.5.2.2 Canada Herpes Marker Testing Market by Distribution Channel
9.1.5.3 Mexico Herpes Marker Testing Market
9.1.5.3.1 Mexico Herpes Marker Testing Market by Type
9.1.5.3.2 Mexico Herpes Marker Testing Market by Distribution Channel
9.2. EUROPE
9.2.1 Europe Herpes Marker Testing Market Overview
9.2.2 Europe Herpes Marker Testing Market Forecasts and Analysis
9.2.3 Europe Herpes Marker Testing Market Forecasts and Analysis - By Type
9.2.4 Europe Herpes Marker Testing Market Forecasts and Analysis - By Distribution Channel
9.2.5 Europe Herpes Marker Testing Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Herpes Marker Testing Market
9.2.5.1.1 Germany Herpes Marker Testing Market by Type
9.2.5.1.2 Germany Herpes Marker Testing Market by Distribution Channel
9.2.5.2 France Herpes Marker Testing Market
9.2.5.2.1 France Herpes Marker Testing Market by Type
9.2.5.2.2 France Herpes Marker Testing Market by Distribution Channel
9.2.5.3 Italy Herpes Marker Testing Market
9.2.5.3.1 Italy Herpes Marker Testing Market by Type
9.2.5.3.2 Italy Herpes Marker Testing Market by Distribution Channel
9.2.5.4 Spain Herpes Marker Testing Market
9.2.5.4.1 Spain Herpes Marker Testing Market by Type
9.2.5.4.2 Spain Herpes Marker Testing Market by Distribution Channel
9.2.5.5 United Kingdom Herpes Marker Testing Market
9.2.5.5.1 United Kingdom Herpes Marker Testing Market by Type
9.2.5.5.2 United Kingdom Herpes Marker Testing Market by Distribution Channel
9.2.5.6 Rest of Europe Herpes Marker Testing Market
9.2.5.6.1 Rest of Europe Herpes Marker Testing Market by Type
9.2.5.6.2 Rest of Europe Herpes Marker Testing Market by Distribution Channel
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Herpes Marker Testing Market Overview
9.3.2 Asia-Pacific Herpes Marker Testing Market Forecasts and Analysis
9.3.3 Asia-Pacific Herpes Marker Testing Market Forecasts and Analysis - By Type
9.3.4 Asia-Pacific Herpes Marker Testing Market Forecasts and Analysis - By Distribution Channel
9.3.5 Asia-Pacific Herpes Marker Testing Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Herpes Marker Testing Market
9.3.5.1.1 Australia Herpes Marker Testing Market by Type
9.3.5.1.2 Australia Herpes Marker Testing Market by Distribution Channel
9.3.5.2 China Herpes Marker Testing Market
9.3.5.2.1 China Herpes Marker Testing Market by Type
9.3.5.2.2 China Herpes Marker Testing Market by Distribution Channel
9.3.5.3 India Herpes Marker Testing Market
9.3.5.3.1 India Herpes Marker Testing Market by Type
9.3.5.3.2 India Herpes Marker Testing Market by Distribution Channel
9.3.5.4 Japan Herpes Marker Testing Market
9.3.5.4.1 Japan Herpes Marker Testing Market by Type
9.3.5.4.2 Japan Herpes Marker Testing Market by Distribution Channel
9.3.5.5 South Korea Herpes Marker Testing Market
9.3.5.5.1 South Korea Herpes Marker Testing Market by Type
9.3.5.5.2 South Korea Herpes Marker Testing Market by Distribution Channel
9.3.5.6 Rest of Asia-Pacific Herpes Marker Testing Market
9.3.5.6.1 Rest of Asia-Pacific Herpes Marker Testing Market by Type
9.3.5.6.2 Rest of Asia-Pacific Herpes Marker Testing Market by Distribution Channel
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Herpes Marker Testing Market Overview
9.4.2 Middle East and Africa Herpes Marker Testing Market Forecasts and Analysis
9.4.3 Middle East and Africa Herpes Marker Testing Market Forecasts and Analysis - By Type
9.4.4 Middle East and Africa Herpes Marker Testing Market Forecasts and Analysis - By Distribution Channel
9.4.5 Middle East and Africa Herpes Marker Testing Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Herpes Marker Testing Market
9.4.5.1.1 South Africa Herpes Marker Testing Market by Type
9.4.5.1.2 South Africa Herpes Marker Testing Market by Distribution Channel
9.4.5.2 Saudi Arabia Herpes Marker Testing Market
9.4.5.2.1 Saudi Arabia Herpes Marker Testing Market by Type
9.4.5.2.2 Saudi Arabia Herpes Marker Testing Market by Distribution Channel
9.4.5.3 U.A.E Herpes Marker Testing Market
9.4.5.3.1 U.A.E Herpes Marker Testing Market by Type
9.4.5.3.2 U.A.E Herpes Marker Testing Market by Distribution Channel
9.4.5.4 Rest of Middle East and Africa Herpes Marker Testing Market
9.4.5.4.1 Rest of Middle East and Africa Herpes Marker Testing Market by Type
9.4.5.4.2 Rest of Middle East and Africa Herpes Marker Testing Market by Distribution Channel
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Herpes Marker Testing Market Overview
9.5.2 South and Central America Herpes Marker Testing Market Forecasts and Analysis
9.5.3 South and Central America Herpes Marker Testing Market Forecasts and Analysis - By Type
9.5.4 South and Central America Herpes Marker Testing Market Forecasts and Analysis - By Distribution Channel
9.5.5 South and Central America Herpes Marker Testing Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Herpes Marker Testing Market
9.5.5.1.1 Brazil Herpes Marker Testing Market by Type
9.5.5.1.2 Brazil Herpes Marker Testing Market by Distribution Channel
9.5.5.2 Argentina Herpes Marker Testing Market
9.5.5.2.1 Argentina Herpes Marker Testing Market by Type
9.5.5.2.2 Argentina Herpes Marker Testing Market by Distribution Channel
9.5.5.3 Rest of South and Central America Herpes Marker Testing Market
9.5.5.3.1 Rest of South and Central America Herpes Marker Testing Market by Type
9.5.5.3.2 Rest of South and Central America Herpes Marker Testing Market by Distribution Channel
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL HERPES MARKER TESTING MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Middle East and Africa
10.5 South and Central America
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. HERPES MARKER TESTING MARKET, KEY COMPANY PROFILES
12.1. ABCAM PLC
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. BIOMAERIEUX SA
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. THERMO FISHER SCIENTIFIC, INC.
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. F. HOFFMANN-LA ROCHE LTD.
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. DIASORIN S.P.A.
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. QUIDEL CORPORATION
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. LUMINEX CORPORATION
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. MERCK KGAA
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. QIAGEN N.V.
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. NORGEN BIOTEK CORP.
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
1. Abcam Plc
2. BioMaerieux SA
3. Thermo Fisher Scientific, Inc.
4. F. Hoffmann-La Roche Ltd.
5. DiaSorin S.p.A.
6. Quidel Corporation
7. Luminex Corporation
8. Merck KGaA
9. Qiagen N.V.
10. Norgen Biotek Corp.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For